Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)LeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Amylyx Pharmaceuticals (AMLX) Long-Term Debt Issuances (2021 - 2025)

Amylyx Pharmaceuticals (AMLX) has 2 years of Long-Term Debt Issuances data on record, last reported at -$375000.0 in Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to -$375000.0; the TTM value through Dec 2025 reached $256.3 million, changed N/A, while the annual FY2025 figure was $256.3 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached -$375000.0 in Q4 2025 per AMLX's latest filing, down from $191.1 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $191.1 million in Q3 2025 and bottomed at -$375000.0 in Q4 2025.